-transparent.png){kind=logo}
We have investigated the incorporation of cholesterol oxidation products into cardiomyocyte lipids and related this to changes in cell proliferation, evaluated by measuring cellular protein content. Primary cultures of neonatal rat ventricular cells were supplemented with scalar concentrations of several cholesterol oxidation products (cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol, 5 alpha-cholestane-3 beta, 5, 6 beta-triol, 5-cholesten-3 beta, 4 beta-diol, 5-cholesten-3 beta-ol-7-one, and 5-cholesten-3-one). Although all the cholesterol oxidation products were incorporated into the cardiomyocyte lipids when added to the medium at a concentration higher than 0.5 microM, the extent of the incorporation of the different cholesterol oxidation products differed, depending on the concentration in the culture medium and on the chemical structure of the compound. The effects of the cholesterol oxidation products on the cellular protein content were also different: 5 alpha-cholestane-3 beta, 5, 6 beta-triol was shown to be the most potent inhibitor of cell proliferation, followed by cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol, 5-cholesten-3 beta, 4 beta-diol and 5-cholesten-3 beta-ol-7-one. 5-Cholesten-3-one did not affect the cellular protein content. The ability of cholesterol oxidation products to inhibit cell proliferation, and their capacity to increase the permeability of the plasma membrane to calcium, could be deleterious for cardiac cells.
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
August 1997,
Lipids,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
September 2016,
Chemistry and physics of lipids,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
January 1997,
Biochemistry and cell biology = Biochimie et biologie cellulaire,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
January 1976,
Biochemical Society transactions,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
November 1970,
Lipids,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
January 1991,
Voprosy meditsinskoi khimii,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
October 2014,
Biochimica et biophysica acta,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
December 1971,
Experientia,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
January 2004,
Xenobiotica; the fate of foreign compounds in biological systems,
A Bordoni, and
S Hrelia, and
M F Caboni, and
G Lercker, and
P L Biagi
May 1979,
The American journal of clinical nutrition,
